Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Expert Review of Anti-Infective Therapy|January 8, 2021
How effective are rapid diagnostic tests for Chagas disease?Maria-Jesus Pinazo, Joaquim Gascon, Julio Alonso-Padilla
Acta Tropica|July 19, 2015
The importance of the multidisciplinary approach to deal with the new epidemiological scenario of Chagas disease (global health)Maria-Jesus Pinazo, Joaquim Gascon
Parasites & Vectors|June 27, 2021
Amaryllidaceae plants: a potential natural resource for the treatment of Chagas diseaseNieves Martínez-Peinado, Nuria Cortes-Serra, Luciana R Tallini, et al.
Parasites & Vectors|June 12, 2020
Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activityNieves Martinez-Peinado, Nuria Cortes-Serra, Laura Torras-Claveria, et al.
Microorganisms|March 6, 2021
Identification of <i>Trypanosoma cruzi</i> Growth Inhibitors with Activity In Vivo within a Collection of Licensed DrugsNieves Martinez-Peinado, Nuria Cortes-Serra, Julian Sherman, et al.
International Journal of Molecular Sciences|January 15, 2021
Anti-<i>Trypanosoma cruzi</i> Activity of Metabolism Modifier CompoundsNieves Martinez-Peinado, Clara Martori, Nuria Cortes-Serra, et al.
Expert Review of Molecular Diagnostics|June 6, 2017
Molecular diagnostics for Chagas disease: up to date and novel methodologiesJulio Alonso-Padilla, Montserrat Gallego, Alejandro G Schijman, et al.
Microorganisms|February 25, 2023
Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against <i>Trypanosoma cruzi</i>Nieves Martinez-Peinado, Juan Carlos Gabaldon-Figueira, Ignacio Martinez-Añon, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 30, 2022
Anti-Trypanosoma cruzi activity of alkaloids isolated from Habranthus brachyandrus (Amaryllidaceae) from ArgentinaNieves Martinez-Peinado, Javier E Ortiz, Nuria Cortes-Serra, et al.
Expert Opinion on Investigational Drugs|July 9, 2020
Emerging agents for the treatment of Chagas disease: what is in the preclinical and clinical development pipeline?Nieves Martínez-Peinado, Nuria Cortes-Serra, Irene Losada-Galvan, et al.
Pageof 16